Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double-Blind Clinical Trial of Tongjiang Theory and Syndrome Differentiation Serial Prescriptions Combined With Proton Pump Inhibitors(PPIs)Descending Ladder Withdrawal for the Treatment of Nonerosive Reflux Disease.

NCT04340297 is registered in ClinicalTrials.gov with Xiyuan Hospital of China Academy of Chinese Medical Sciences as lead sponsor.

NCT NCT04340297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04340297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double-Blind Clinical Trial of Tongjiang Theory and Syndrome Differentiation Serial Prescriptions Combined With Proton Pump Inhibitors(PPIs)Descending Ladder Withdrawal for the Treatment of Nonerosive Reflux Disease.
Lead sponsor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phase
Phase 3
Overall status
Unknown status
Start date
June 15, 2020
Completion date
December 31, 2021
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nonerosive reflux disease